Testing metformin for thinking and brain growth in children after brain tumor treatment

Official title: Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.

The trial team last updated this record on .

The short version

This trial tests a drug called metformin in young people who finished brain tumor treatment.

Read our full plain-language summary

What the trial team says

The efficacy of treatment with metformin for promoting cognitive recovery and brain growth in children/adolescents treated for a brain tumour will be investigated in a multi-site Phase III randomized double-blind placebo-controlled parallel arm superiority trial. Specifically, in children/adolescents aged 7 years to 21 years and 11 months who have completed treatment for a brain tumour, is oral administration of metformin for 16 weeks associated with greater improvement of cognitive function and brain growth compared to placebo administered for 16 weeks?

From the trial's own listing on ClinicalTrials.gov.

Key facts

Registry number
NCT05230758
Stage of testing
Phase 3
Conditions studied
Medulloblastoma, Childhood, Cognitive Impairment

Where it is running

This trial lists 20 sites.

How to use this

Talk to your care team first. They know your history and can tell you whether this trial is worth your time.

Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.

See the full listing on ClinicalTrials.gov

This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.